Novel pulmonary presentation of mycobacterium interjectum

Adam W. Bagley, Jaspal S Gujral

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Nontuberculous mycobacteria (NTM) have been shown to cause disseminated disease in immunocompromised individuals as well as local infection in the immunocompetent. In 2006, the incidence of NTM disease varied from 1.0 to 1.8 cases per 100,000 in industrialised countries. The number of NTM species and diagnoses have increased dramatically as a result of improved isolation techniques and sequencing of the 16S rRNA as a standard for identifying new species. The NTM known as Mycobacterium interjectum has been well documented as a source of infection in children and immunocompromised adults; however, there are no descriptions of disease in healthy individuals. To date, no human-to-human transmission has been described, and infections are believed to be acquired from environmental exposure. The following is a description of significant pulmonary disease in an immunocompetent gentleman with M. interjectum as the identified pathogen.

Original languageEnglish (US)
Pages (from-to)128-130
Number of pages3
JournalJournal, Indian Academy of Clinical Medicine
Volume11
Issue number2
StatePublished - Apr 1 2010

Fingerprint

Nontuberculous Mycobacteria
Mycobacterium
Lung
Infection
Environmental Exposure
Developed Countries
Lung Diseases
Incidence

Keywords

  • Chest wall abscess
  • Mycobacterium interjectum
  • Nontuberculous mycobacteria

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Novel pulmonary presentation of mycobacterium interjectum. / Bagley, Adam W.; Gujral, Jaspal S.

In: Journal, Indian Academy of Clinical Medicine, Vol. 11, No. 2, 01.04.2010, p. 128-130.

Research output: Contribution to journalArticle

@article{adcf5054ddf2492780d1d7021c27c1fe,
title = "Novel pulmonary presentation of mycobacterium interjectum",
abstract = "Nontuberculous mycobacteria (NTM) have been shown to cause disseminated disease in immunocompromised individuals as well as local infection in the immunocompetent. In 2006, the incidence of NTM disease varied from 1.0 to 1.8 cases per 100,000 in industrialised countries. The number of NTM species and diagnoses have increased dramatically as a result of improved isolation techniques and sequencing of the 16S rRNA as a standard for identifying new species. The NTM known as Mycobacterium interjectum has been well documented as a source of infection in children and immunocompromised adults; however, there are no descriptions of disease in healthy individuals. To date, no human-to-human transmission has been described, and infections are believed to be acquired from environmental exposure. The following is a description of significant pulmonary disease in an immunocompetent gentleman with M. interjectum as the identified pathogen.",
keywords = "Chest wall abscess, Mycobacterium interjectum, Nontuberculous mycobacteria",
author = "Bagley, {Adam W.} and Gujral, {Jaspal S}",
year = "2010",
month = "4",
day = "1",
language = "English (US)",
volume = "11",
pages = "128--130",
journal = "Journal, Indian Academy of Clinical Medicine",
issn = "0972-3560",
publisher = "Indian Academy of Clinical Medicine",
number = "2",

}

TY - JOUR

T1 - Novel pulmonary presentation of mycobacterium interjectum

AU - Bagley, Adam W.

AU - Gujral, Jaspal S

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Nontuberculous mycobacteria (NTM) have been shown to cause disseminated disease in immunocompromised individuals as well as local infection in the immunocompetent. In 2006, the incidence of NTM disease varied from 1.0 to 1.8 cases per 100,000 in industrialised countries. The number of NTM species and diagnoses have increased dramatically as a result of improved isolation techniques and sequencing of the 16S rRNA as a standard for identifying new species. The NTM known as Mycobacterium interjectum has been well documented as a source of infection in children and immunocompromised adults; however, there are no descriptions of disease in healthy individuals. To date, no human-to-human transmission has been described, and infections are believed to be acquired from environmental exposure. The following is a description of significant pulmonary disease in an immunocompetent gentleman with M. interjectum as the identified pathogen.

AB - Nontuberculous mycobacteria (NTM) have been shown to cause disseminated disease in immunocompromised individuals as well as local infection in the immunocompetent. In 2006, the incidence of NTM disease varied from 1.0 to 1.8 cases per 100,000 in industrialised countries. The number of NTM species and diagnoses have increased dramatically as a result of improved isolation techniques and sequencing of the 16S rRNA as a standard for identifying new species. The NTM known as Mycobacterium interjectum has been well documented as a source of infection in children and immunocompromised adults; however, there are no descriptions of disease in healthy individuals. To date, no human-to-human transmission has been described, and infections are believed to be acquired from environmental exposure. The following is a description of significant pulmonary disease in an immunocompetent gentleman with M. interjectum as the identified pathogen.

KW - Chest wall abscess

KW - Mycobacterium interjectum

KW - Nontuberculous mycobacteria

UR - http://www.scopus.com/inward/record.url?scp=77954262954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954262954&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77954262954

VL - 11

SP - 128

EP - 130

JO - Journal, Indian Academy of Clinical Medicine

JF - Journal, Indian Academy of Clinical Medicine

SN - 0972-3560

IS - 2

ER -